Interferon beta-1b-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) in a patient treated for multiple sclerosis: A case report

  • Masoud Etemadifar Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  • Fatemeh Sabeti Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  • Mehri Salari Department of Neurology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Keywords: Multiple Sclerosis, Thrombotic Thrombocytopenic Purpura, Interferon-Beta

Abstract

Interferon beta-1b-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) in a patient treated for multiple sclerosis: A case report

References

1. Shenkman B, Einav Y. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: Diagnosis and classification. Autoimmun Rev 2014; 13(4-5): 584-6.
2. Nangaku M, Nishi H, Fujita T.Pathogenesis and prognosis of thrombotic microangiopathy. Clin Exp Nephrol 2007; 11(2): 107-14.
3. Vosoughi R, Marriott JJ. Thrombotic microangiopathy in interferon beta treated multiple sclerosis patients: Review of literature and report of two new cases. Mult Scler Relat Disord 2014; 3(3): 321-5.
4. Ben-Amor AF, Trochanov A, Fischer TZ. Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome reports with subcutaneous interferon beta-1a. AdvTher 2015; 32(5): 445-54.
5. Moake J. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies. Best Pract Res Clin Haematol 2009; 22(4): 567-76.
Published
2018-04-07
How to Cite
1.
Etemadifar M, Sabeti F, Salari M. Interferon beta-1b-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) in a patient treated for multiple sclerosis: A case report. IJNL. 17(2):91-4.
Section
Clinical Note(s)